结构形式是否重要? 对医疗大宗商品的采购机制的比较分析
Koray Parmaksiz1, Hester van de Bovenkamp2, Roland Bal2
1Erasmus School of Health Policy & Management, Erasmus University Rotterdam, Rotterdam, The Netherlands. korayparmaksiz@gmail.com.
Globalization and health
|November 23, 2023
概括
聚合采购机制,无论是买方所有还是第三方,都需要不同程度的买方对齐才能取得成功. 购买者拥有的模型需要统一性和共同目标,而第三方模型则依赖于适应组织.
科学领域:
- 卫生政策和健康管理
- 供应链管理 供应链管理
- 国际卫生经济学 国际卫生经济学
背景情况:
- 聚合采购,一个合作买家倡议,在COVID-19大流行期间获得了突出地位,以提高获得健康商品的机会.
- 机制范围从买家拥有的协作模式到第三方管理的组织.
- 对于这些不同的聚合采购结构的独特特征,实施和开发流程的了解有限.
研究的目的:
- 为了比较买家所有和第三方合并采购机制的特点,实施和发展过程.
- 确定影响不同聚合采购模式成功的因素.
主要方法:
- 采用了定性多个案例研究设计.
- 四个聚合采购机制是有目的地选择的:两个是买方拥有的 (东加勒比国家和太平洋岛国组织) 和两个是第三方 (全球药物设施和喘药物设施).
- 数据采集使用了"合并采购指南",同行评审文章,灰色文献和采购专家的半结构面试.
主要成果:
- 购买者拥有的机制需要购买者在采购系统,融资,产品需求和法律框架方面更加一致,特别是当购买者是一致的并且感知到迫切的问题时.
- 第三方机制需要较少的买家对买家的共识,而是专注于与第三方组织的运营保持一致.
- 成功的第三方机制取决于秘书处提高认识,培养政治意愿,确保资金和吸引熟练人员的能力.
结论:
- 维持聚合采购机制需要持续的利益相关者参与,强有力的资金动员,以及利益和需求的战略调整.
- 聚合采购的成功取决于将策略适应特定的模式 (买方所有与第三方) 以及参与买方的背景.
关键词:
喘药物设施 (ADF) 的情况集中采购的集中采购方式发展阶段 发展阶段全球药物设施 (GDF)联合采购 联合采购 联合采购药品 药品 药品 药品 药品东加勒比国家组织 (OECS)太平洋岛屿国家 (PIC)药品制品制品制品制品制品制品制品制品制聚合采购的采购方式更多相关视频
00:04A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
10.7K
07:25In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
Published on: May 4, 2017
17.8K
相关概念视频
01:26Methods Of Healthcare Delivery System
3.3K
At the different levels of the healthcare system, we see varying methods of healthcare used. These methods include managed care systems, case management, and primary healthcare.
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
3.3K
01:30Health Information Technology and Healthcare Information System
846
Health Information Technology (HIT)
Health Information Technology, commonly called HIT, integrates advanced information systems and technology in healthcare settings. Its primary functions include:
Health Information Technology, commonly called HIT, integrates advanced information systems and technology in healthcare settings. Its primary functions include:
846
01:16Bioequivalence: Overview
1.1K
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
1.1K
01:28International Nursing Organizations II
1.0K
The World Health Organization (WHO) is a specialized agency of the United Nations based in Geneva. The WHO has many initiatives that center around health. Primarily, they lead global efforts to expand universal health coverage using science-based policies and programs. They are also responsible for shaping health research agendas and developing norms and standards.
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
1.0K
01:20Comparing the Survival Analysis of Two or More Groups
199
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
199
01:12Hazard Ratio
134
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
134